Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044163
Filing Date
2024-11-08
Accepted
2024-11-08 08:20:41
Documents
60
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 734248
2 ex31-1.htm EX-31.1 11676
3 ex32-1.htm EX-32.1 3834
  Complete submission text file 0001493152-24-044163.txt   3629955

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20240930.xsd EX-101.SCH 31925
5 XBRL CALCULATION FILE pulm-20240930_cal.xml EX-101.CAL 45777
6 XBRL DEFINITION FILE pulm-20240930_def.xml EX-101.DEF 100495
7 XBRL LABEL FILE pulm-20240930_lab.xml EX-101.LAB 250302
8 XBRL PRESENTATION FILE pulm-20240930_pre.xml EX-101.PRE 187026
62 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 473017
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 241438082
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)